Elevance Health, Inc. (ELV) स्टॉक विश्लेषण

कंपनी का अवलोकन

Elevance Health, Inc. operates as a prominent health benefits entity within the United States, delivering a comprehensive array of health plans and specialized services to individual consumers and employer groups. The organization functions across the Healthcare sector and specifically within the Healthcare Plans industry, which positions it as a critical intermediary managing patient care costs and access. This enterprise employs a substantial workforce of 96,129 individuals, reflecting its extensive operational footprint and administrative complexity. With a market capitalization of $69.93B and annualized revenue reaching $199.13B, Elevance Health demonstrates significant scale, indicating its status as a major systemic player capable of influencing market dynamics and negotiating power within the national healthcare ecosystem.

वित्तीय स्वास्थ्य

The company reported a trailing twelve-month revenue of $199.13B with a corresponding net income of $5.66B and an EBITDA of $9.04B. The substantial disparity between the gross revenue figure and the final net income highlights a significant cost structure, where operating expenses, claims payments, and administrative costs consume the majority of top-line earnings before arriving at the bottom line. Free cash flow stands at $3.40B, providing the firm with considerable financial flexibility to fund operational needs, invest in technology infrastructure, or manage capital allocation strategies without immediate reliance on external financing. Profitability is segmented into a gross margin of 25.6%, an operating margin of 1.5%, and a profit margin of 2.8%, illustrating the intense cost pressures inherent in the managed care model where margins are compressed by regulatory and competitive forces. On the balance sheet, the company holds $36.12B in cash against $32.75B in debt, resulting in a debt-to-equity ratio of 74.39%, which suggests a leveraged capital structure where equity obligations exceed debt burdens but remain substantial. Liquidity is supported by a current ratio of 1.53, indicating that short-term assets are more than sufficient to cover immediate liabilities, thereby ensuring operational stability. Return on equity is recorded at 13.2% while return on assets sits at 4.4%, metrics that collectively reveal management's effectiveness in generating returns on shareholder capital relative to the total asset base utilized to support operations.

मूल्यांकन आकलन

Valuation multiples for Elevance Health show a trailing P/E ratio of 12.56 compared to a forward P/E of 10.76, implying that the market anticipates an expansion in earnings growth that would lower the valuation multiple over the next fiscal period. The price-to-book ratio is 1.59, suggesting that the market values the company's equity at a moderate premium above its accounting book value, reflecting intangible assets and brand strength. Alternative valuation metrics such as a price-to-sales ratio of 0.35 and an EV/EBITDA of 7.38 provide context for revenue generation efficiency and enterprise value relative to cash earnings, indicating a valuation that is relatively sensitive to sales volume fluctuations. Historical price volatility is bounded by a 52-week high of $458.75 and a low of $273.71, where the current trading position reflects the dynamic range of investor sentiment over the last year. The stock exhibits a beta of 0.50, signifying that its price movements are less volatile than the broader market, offering a characteristic profile of lower systematic risk for long-term capital preservation strategies.

Growth & Income

Revenue growth stands at 9.5% year-over-year while earnings growth accelerates at 36.3% year-over-year, indicating that profitability is expanding at a significantly faster pace than top-line sales, likely driven by pricing power, utilization management, or operational efficiency gains. As a dividend payer, the company distributes a yield of 2.2% with a payout ratio of 27.1%, a conservative level that suggests high sustainability given the robust earnings growth and ample free cash flow generation. The low payout ratio relative to earnings growth allows the company to retain a significant portion of profits for reinvestment or debt reduction rather than distributing all earnings to shareholders. Overall, the growth and income profile presents a scenario of accelerating profitability supported by a sustainable and conservative dividend policy within a moderately volatile market environment.